Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cooper

Showing results (1301-1310 of 1,657) with videos related to

Pageof 166
Sort By:
Journal of Molecular Biology|September 5, 2006
High resolution structure of BipD: an invasion protein associated with the type III secretion system of Burkholderia pseudomalleiP T Erskine, M J Knight, A Ruaux, et al.
Circulation. Heart Failure|August 13, 2016
Implications of Using Different Definitions on Outcomes in Worsening Heart FailureJacob P Kelly, Lauren B Cooper, Dianne Gallup, et al.
JAMA|March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trialH A Sackeim, R F Haskett, B H Mulsant, et al.
Bioorganic & Medicinal Chemistry|December 8, 2019
Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacologyHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Journal of Cardiac Failure|February 20, 2016
Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACSPrateeti Khazanie, Bradley G Hammill, Chetan B Patel, et al.
BMC Pulmonary Medicine|December 13, 2022
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trialAnna J Podolanczuk, John S Kim, Christopher B Cooper, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced SolubilityAndrew M Thompson, Patrick D O'Connor, Vanessa Yardley, et al.
American Heart Journal|March 5, 2019
Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM TrialAbhinav Sharma, Robert J Mentz, Bradi B Granger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
BMC Chemistry|July 27, 2023
Ultra-high resolution X-ray structure of orthorhombic bovine pancreatic Ribonuclease A at 100KDavid R Lisgarten, Rex A Palmer, Jon B Cooper, et al.
Pageof 166

Showing results (1301-1310 of 1,657) with videos related to

Sort By:
Pageof 166
Journal of Molecular Biology|September 5, 2006
High resolution structure of BipD: an invasion protein associated with the type III secretion system of Burkholderia pseudomalleiP T Erskine, M J Knight, A Ruaux, et al.
Circulation. Heart Failure|August 13, 2016
Implications of Using Different Definitions on Outcomes in Worsening Heart FailureJacob P Kelly, Lauren B Cooper, Dianne Gallup, et al.
JAMA|March 20, 2001
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trialH A Sackeim, R F Haskett, B H Mulsant, et al.
Bioorganic & Medicinal Chemistry|December 8, 2019
Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacologyHamish S Sutherland, Amy S T Tong, Peter J Choi, et al.
Journal of Cardiac Failure|February 20, 2016
Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACSPrateeti Khazanie, Bradley G Hammill, Chetan B Patel, et al.
BMC Pulmonary Medicine|December 13, 2022
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trialAnna J Podolanczuk, John S Kim, Christopher B Cooper, et al.
ACS Medicinal Chemistry Letters|February 19, 2021
Novel Linker Variants of Antileishmanial/Antitubercular 7-Substituted 2-Nitroimidazooxazines Offer Enhanced SolubilityAndrew M Thompson, Patrick D O'Connor, Vanessa Yardley, et al.
American Heart Journal|March 5, 2019
Utilizing mobile technologies to improve physical activity and medication adherence in patients with heart failure and diabetes mellitus: Rationale and design of the TARGET-HF-DM TrialAbhinav Sharma, Robert J Mentz, Bradi B Granger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
High-dose cytarabine and daunorubicin as consolidation therapy for acute myeloid leukemia in first remission: long-term follow-up and resultsS N Wolff, R H Herzig, J W Fay, et al.
BMC Chemistry|July 27, 2023
Ultra-high resolution X-ray structure of orthorhombic bovine pancreatic Ribonuclease A at 100KDavid R Lisgarten, Rex A Palmer, Jon B Cooper, et al.
Pageof 166